Smooth muscle cells (SMC) of the bladder undergo hypertrophy and hyperplasia following exposure to sustained mechanical overload. Although superficial similarities in the response of the heart and bladder to hypertrophic stimuli suggest that similar molecular mechanisms may be involved, this remains to be demonstrated. In this study we compared signal transduction pathway activation in primary culture bladder SMC and cardiac myofibroblasts in response to cyclic stretch. The effects of growth factor stimulation on pathway activation in bladder SMC were also investigated.Primary culture rodent bladder SMC or cardiac myofibroblasts were subjected to cyclic stretch-relaxation in the absence or presence of pharmacologic inhibitors of the phosphoinositide-3-kinase, (PI3K)/Akt, extracellular signal-regulated kinase-mitogen activated protein kinase (Erk-MAPK) or the p38 stress-activated protein kinase-2 (SAPK2) pathways. In parallel experiments human bladder SMC were treated with platelet-derived growth factor-BB (PDGF-BB), heparin-binding EGF-like growth factor (HB-EGF) or fibroblast growth factor-2 (FGF-2). In each case the extent of DNA synthesis was determined by uptake of tritiated thymidine, and activation of specific signaling intermediates was determined by immunoblot analysis using antibodies to the non-phosphorylated and phosphorylated (activated) forms of Akt, p38 and Erk1/2.Akt and p38 were rapidly phosphorylated in stretched bladder SMC and cardiac myofibroblasts, and stretch-induced DNA synthesis in these cells was ablated with inhibitors of PI3K or p38 but not Erk-MAPK. Similarly, PDGF-BB up-regulated DNA synthesis in bladder SMC in a p38 and Akt-dependent manner.We conclude that distinct stimuli, such as mechanical stretch and PDGF-BB, promote DNA synthesis in bladder SMC through shared downstream signaling pathways. Furthermore, phenotypically similar cells from the bladder and heart show comparable pathway activation in response to stretch. These findings suggest that similar molecular mechanisms underlie the altered growth responses of the bladder and heart to mechanical overload. This study also provides the first report of Akt activation in bladder SMC and suggests that Akt, consistent with its pivotal role in cardiac hypertrophy, may also be a key regulator of remodeling in the SMC compartment of the bladder exposed to hypertrophic/hyperplastic stimuli in vivo.
Flexible ureteroscopes are widely used for inspection, access, and manipulation in the ureter and kidney during uretero-renoscopy. However, existing endoscope designs rely on decades-old manual controls for translation, rotation, and tip flexion. The development of a more intuitive and user-friendly control system has the potential to greatly enhance the safety, efficacy, and efficiency of endoscopic procedures. Based on a first generation prototype, our lab designed an ergonomically enhanced flexible endoscopy robotic system. The system was designed to enable the surgeon to operate the endoscope through a low cost game controller. The kinematics were analyzed considering the nonlinearity of flexion driving and cable slack. The kinematics control was combined with the direct control for the system. The initial evaluations show the feasibility of this approach.
Galen and Leonardo da Vinci were the first to propose that normal UVJ allowed unidirectional flow ofurine into the bladder and that VUR might be abnormal in humans.1,2 In 1893, Pozzi reported that VUR could occur in humans after noting an unexpected urine leakage from the accidentally severed ureter during a pelvic gynecologic procedure.3 The systematic identification of VUR came as the result of technologic advances in contrast radiography – voiding cystourethrography (VCUG). Initially, VUR was not thought to be a significant clinical problem for humans, although Bumpus speculated in 1924 that VUR was related to UTI and that in children, unlike adults, VUR was not associated with other urinary tract pathology.4 In 1930, Campbell found VUR in 12% of over 700 VCUGs but assumed that there was other underlying pathology as the cause of VUR.5 In 1944, Prather proposed that VUR was abnormal in children,6 and this notion gained increasing acceptance, after accumulating evidence suggested that VUR was typically absent in normal neonates and children. The modern era of clinical VUR management was ushered in by Hutch's observation that VUR and pyelonephritis might be causally related in paraplegic patients.7 Hodson, applying Hutch's concept to children, noted that VUR was more common in children with UTI and renal parenchymal abnormality.8,9 Other clinical and experimental observations soon followed, providing the anatomic and functional basis for the UVJ mechanism and the etiology of VUR.